Keyphrases
Genetic Variants
100%
Outcome Prediction
100%
Biochemical Recurrence
100%
Localized Prostate Cancer
100%
Protein Variants
100%
Serum Proteins
100%
Immune Checkpoint
100%
Biochemical Progression
83%
CD80
66%
Genotype
33%
MRNA Expression
33%
Aggressiveness
33%
Genetic Variation
33%
Single nucleotide Polymorphism
33%
Recurrence Risk
33%
Risk of Progression
33%
Prostate Cancer
16%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
16%
CD28
16%
Prognostic Value
16%
Serum Levels
16%
Statistical Analysis
16%
Meta-analysis
16%
Biological Mechanisms
16%
Clinical Predictors
16%
Tumor Aggressiveness
16%
Programmed Death-ligand 1 (PD-L1)
16%
Functional Data
16%
CD27
16%
Validation Cohort
16%
Serum Biomarkers
16%
Prostate Cancer Outcomes
16%
4-1BB
16%
Protein Variation
16%
PD-L2
16%
Tim-3
16%
Prostate Cancer Aggressiveness
16%
ArrayExpress
16%
Biochemistry, Genetics and Molecular Biology
Genetic Divergence
100%
Cohort Study
100%
Serum Total Protein
100%
Immune Checkpoints
100%
CD80
66%
Messenger RNA
50%
Single-Nucleotide Polymorphism
33%
Genetic Variation
33%
BTLA
33%
Blood Level
16%
PD-L1
16%
CD28
16%
CTLA-4
16%
CD27
16%
Immunology and Microbiology
Immunity
100%
CD80
100%
Single Nucleotide Polymorphism
50%
Genetic Variation
50%
Antiserum
50%
B-And T Lymphocyte Attenuator
50%
CD28
25%
CTLA-4
25%
Blood Level
25%
Programmed Death-Ligand 1
25%